CBC Group, formerly known as C-Bridge Capital, is a leading healthcare-focused asset management firm in Asia. They primarily invest in innovative healthcare companies across various stages, from early-stage to growth and buyout opportunities. The firm's geographical focus spans Asia, North America, and Europe, with a typical investment size ranging from $50 million to $200 million.

CBC Group's portfolio includes notable companies such as Adcentrx Therapeutics, AffaMed Therapeutics, and NiKang Therapeutics. The firm leverages its extensive network and expertise to facilitate cross-border investments and strategic alliances, particularly between the United States, China, and Israel. CBC Group aims to enhance global healthcare access by partnering with innovators and providing value-added services to their portfolio companies.